ARKG241206C28000
- 0.05
- 0.000.00%
ARK Genomic Revolution ETF Newsroom
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Recursion Announces First Patient Dosed In Phase 1/2 Clinical Study Of REC-1245, A RBM39 Degrader For Biomarker-Enriched Solid Tumors And Lymphoma
The hidden winner in the USA election? Cathie Wood's ARKK hit a new high for the year, all thanks to these heavily weighted stocks!
The strong rise of ARKK is mainly attributed to the increase in its heavy holdings, Tesla, and cryptos-related companies, Coinbase and Robinhood.
Looking Into Natera's Recent Short Interest
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
Following nvidia to invest in ai? These three small cap ai stocks are worth attention.
As the current leader in AI technology, nvidia also participates in practical application scenarios of AI+ through investment and shareholding.
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
Natera Announces Its Prospera Lung Test Has Met Coverage Requirements From The Centers For Medicare & Medicaid Services' Molecular Diagnostics Services Program For Single Lung Transplant Recipients; This Coverage Applies To SLT Patients In The...
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Guardant Health Says Jury Unanimously Rejected All Of Natera's Counterclaims And Awarded $292.5M To Company, Including $175.5M In Punitive Damages
Guardant Health Shares Are Trading Higher After a Jury Issued a Decision in the Company's Favor Regarding a False Advertising Case Filed by Natera Concerning Statements Made About Guardant's Reveal Test.
Natera Issues Statement On Guardant Health Litigation; Says "A Jury Issued A Decision In Guardant's Favor. We Disagree With This Decision And Will Ask The Court To Overturn It"
Twist Bioscience Shares Are Trading Higher After Leerink Partners Maintained Its Hold Rating on the Stock.
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Recursion Pharmaceuticals Analyst Ratings
Trump Media Saw the Largest Increase in Short Interest in October
AI software stocks make a big comeback! Applovin's annual growth is 7 times that of Nvidia, which other stocks are worth paying attention to?
Since the end of last year, benefiting from the improvement of large model capabilities and the support of ai infrastructure, ai has gradually driven the commercialization of software on the software side, empowering enterprises to achieve performance growth. After the successive boom in ai hardware, the global market's attention is gradually shifting to software. What signal is the capital sensing?